XanGo is a health and wellness supplement derived from the mangosteen fruit, known for its overwhelming nutritional value and healing properties. The mangosteen fruit is indigenous to Asia, where its byproducts have been used in therapeutic application for centuries. It was not until 2003 when XanGo, a puree of the mangosteen, appeared commercially in Western regions. The makers of XanGo claim at least 1 million independent distributors in the United States alone, with more than 30 countries currently serving its product worldwide.
Marketing
XanGo is distributed through a multi-level marketing (MLM) system. This means that the product is sold to a network of independent marketers directly from the company. It is then retailed by the individual to private users. For this reason, XanGo is not likely to be found on store shelves but, instead, must be purchased through an authorized representative. The MLM model pays for performance and offers the representative a share in the profits of those whom he has also recruited to sell.
Antioxidants
Antioxidants reduce damage caused by free radicals, unstable molecules that attack cells within the body through oxidation. Free radicals are thought to be the primary cause of the cellular breakdown that leads to the symptoms of advanced aging. Because XanGo is a source of antioxidant elements, it has been touted to encourage longevity and slow the signs of age. The anti-inflammatory properties of mangosteen also help to curb the disintegration of tissue caused by chemical stressors.
XanGo
The name Xango is a combination of the words "xanthones" and "mangosteen." Xanthones are natural compounds, high in antioxidant content. XanGo contains more than 40 xanthones, some of which enhance immune function and mental clarity in addition to detaining the aging process.
Alpha Mangostin
XanGo also embodies the qualities of alpha-mangostin, a xathone compound shown to slow the growth of cancer cells in laboratory animals. Alpha mangostin is in the top class of herbal components being examined for their cancer-inhibiting qualities.
FDA Warning
In 2006, the U.S. Food and Drug Administration (FDA) issued a formal warning to the makers of XanGo, claiming that promotional materials mark the product as a means to cure, treat and prevent disease. Such benefits have yet to be substantiated by the FDA, and much research is still needed before the benefits of XanGo are fully understood.
